financetom
Business
financetom
/
Business
/
Kimberly-Clark to pay up to $40 million over sale of adulterated surgical gowns, US DOJ says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kimberly-Clark to pay up to $40 million over sale of adulterated surgical gowns, US DOJ says
Aug 28, 2025 10:43 AM

Aug 28 (Reuters) - Kimberly-Clark Corp ( KMB ) has

agreed to pay up to $40.4 million to resolve a criminal charge

relating to the company's sale of adulterated MicroCool surgical

gowns, the U.S. Justice Department said on Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update On Strathcona; National Bank Comments as the
Update On Strathcona; National Bank Comments as the "SCR MEG Saga Continues"
Sep 8, 2025
10:39 AM EDT, 09/08/2025 (MT Newswires) -- (Adds share price update and National Bank commentary in the third paragraph) Strathcona Resources ( STHRF ) on Monday increased its offer to acquire all of MEG Energy's ( MEGEF ) common shares it does not already own for 0.80 of a Strathcona common share per MEG share. Its previous offer was for...
Market Chatter: Hewlett Packard Enterprise Launches Bond Sale
Market Chatter: Hewlett Packard Enterprise Launches Bond Sale
Sep 8, 2025
10:32 AM EDT, 09/08/2025 (MT Newswires) -- Hewlett Packard Enterprise ( HPE ) is selling investment grade bonds to help refinance debt tied to its Juniper Networks acquisition, Bloomberg reported Monday, citing a person familiar with the matter. The four-part, dollar-denominated offering includes a mix of floating-rate and fixed-rate notes, with the longest maturity at five years, according to the...
LB Pharmaceuticals eyes $322 million valuation in biotech IPO amid sector drought
LB Pharmaceuticals eyes $322 million valuation in biotech IPO amid sector drought
Sep 8, 2025
Sept 8 (Reuters) - Cash-strapped drug developer LB Pharmaceuticals said on Monday it was aiming for a valuation of up to $321.6 million in its New York initial public offering, potentially setting up the first sizable U.S. biotech flotation in months. WHY IT'S IMPORTANT Biotech listings - historically a key driver of U.S. healthcare listings - have slumped this year...
Adobe Likely to Deliver 'Solid' Results Even as GenAI Monetization Remains Key Investor Focus, RBC Says
Adobe Likely to Deliver 'Solid' Results Even as GenAI Monetization Remains Key Investor Focus, RBC Says
Sep 8, 2025
10:42 AM EDT, 09/08/2025 (MT Newswires) -- Adobe (ADBE) is likely to deliver solid fiscal third-quarter results, but competitive pressures around generative artificial intelligence monetization remain key concerns for investors, RBC Capital Markets said in a note e-mailed Monday. The software maker is scheduled to release its quarterly results on Thursday. RBC expects Adobe to report per-share earnings of $5.17...
Copyright 2023-2026 - www.financetom.com All Rights Reserved